The Largest Study on GLP-1 Drugs and Addiction Just Found Something Unexpected, a Doctor Breaks It Down A 2026 BMJ study of over 600,000 patients found that GLP-1 receptor agonists were associated with up to 25 percent lower risk of developing substance use disorders across six different substances simultaneously, including a 50 percent reduction in addiction-related mortality among those already diagnosed
Our registered dietitians provide personalized guidance on creating a healthy and balanced eating plan that aligns with your preferences and nutritional needs
Reta Support does not prescribe water goals, protein goals, nutrition plans, or treatment recommendations
Differential effects of GLP-1RAs on the risk of diverse tumor types Currently, several GLP-1RAs have been approved for the treatment of type 2 diabetes (T2DM) and/or obesity, and emerging evidence suggests that these agents may influence cancer risk
Its mechanism for muscle growth support is indirect: it accelerates the repair of tendons, ligaments, and muscle tissue that would otherwise represent the rate-limiting factor in training progression
.png.jpg)
